Print ISSN: 1683-3589

Online ISSN: 2409-501X

Keywords : Cancer


A CHANGING PATTERN OF CANCER–RELATED MORTALITY IN BASRAH

Basrah Journal of Surgery, 2018, Volume 24, Issue 2, Pages 24-29
DOI: 10.33762/bsurg.2018.160087

Abstract
Cancer is a growing health problem with substantial mortality. A high mortality reflects high incidence, late detection and inadequate management.
The objective of this study is to examine the time changes of mortality rate of cancer in Basrah. The results presented in this article are all based on officially registered cancer deaths in Basrah Governorate on selected years.
Cancer of lung and bronchus, breast cancer, CNS tumors, all types of leukemia, secondaries of unknown primary site, urinary bladder cancer, stomach cancer, cancer of pancreas and cancer of liver and biliary system were the leading causes of cancer related death and accounted for 68.7%. The time trend showed some tendency for mortality rates to increase over years for most cancers except a noticeable decline in recent years.
In conclusion, cancer is a major cause of death in Basrah accounting for nearly 10% of all officially registered deaths. An initial modest increase followed by some tendency to decrease in mortality rate is noticed. Further comprehensive studies are highly recommended.

PATIENTS WITH METASTATIC CANCER OF UNKNOWN PRIMARY SITE: DIAGNOSTIC WORKUP AND THERAPEUTIC MANAGEMENT

Majeed H Alwan

Basrah Journal of Surgery, 2006, Volume 12, Issue 2, Pages 3-9
DOI: 10.33762/bsurg.2006.55353

PATIENTS WITH METASTATIC CANCER OF UNKNOWN PRIMARY SITE: DIAGNOSTIC WORKUP AND THERAPEUTIC MANAGEMENT
Majeed H Alwan
FRCS, FACS, Gastrointestinal and General Surgeon, Wellington Hospital, Wellington, New Zealand
Abstract
Metastatic Cancer of Unknown Primary site (CUP) accounts for about 4% of all cancer patients and is therefore one of the 10 most frequent cancer diagnoses in man. It is defined as biopsy-confirmed malignancy for which the site of origin is not identified by routine workup. It is believed that CUP represents a heterogeneous group of malignancies that have a presumably, specific biology with clinical characteristics of rapid progression and random atypical metastases. The diagnostic work-up could be variable. Certain clinicopathological CUP entities are considered as favorable subsets responding to systemic platinum-based chemotherapy or managed by locoregional treatment. These subsets have a better prognosis than the average median survival time of four months in patients who belong to the non-favorable subsets.